Ovarian cancer difficult and Countermeasures
| Ovarian cancer | ||
| Ovarian cancer | ||
Amenorrhea is common clinical symptoms, their causes are complex, the causes can be divided into the central nervous system and the hypothalamus, pituitary, ovary and uterus of amenorrhea, including congenital Gonadal Dysgenesis and autoimmune ovarian inflammation. As such closure gonadotropin levels often associated with higher estrogen levels decrease, it said hypergonadotropic amenorrhea, gonadotropin levels higher than normal cycle or reached menopause, clinical manifestations of primary or secondary amenorrhea.
Tags: age, amenorrhea, anti, blood, body, cause, clinical, diagnosis, eat, ert, estrogen, examination, gene, ovarian, ovary, patients, pelvic, poor, positive, rate, second, symptoms, time, treatmentOne, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.
One, information and Methods
Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, womenCytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects
Foreign Medical Obstetrics and Gynecology volumes in 1999 Vol 26 No. 2
Tianjin Medical University General Hospital of Obstetrics and Gynecology (300,052) of the new QU (Summary) if Mi (revision)
Abstract <BR> since the 1980s, complete cytoreductive surgery to cisplatin-based combination chemotherapy for ovarian cancer as a conventional model, cytoreductive surgery is the complete impact of the prognosis of patients with one of the important factors for recurrent ovarian cancer once again cytoreductive surgery still some value , but to improve the survival rate of patients is more important to be effective after chemotherapy treatment as a necessary complement. Early ovarian cancer retroperitoneal lymph node dissection is reasonable and significance of the still controversial.
Tags: abdominal, age, annex, anti, bleeding, blood, cancer, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, early, eat, ert, exploration, gene, growth, incidence, increased, intraperitoneal, intravenous, life, lymph, malignant, metastasis, metastatic, method, mutation, node, ovarian, p53, patients, pelvic, physical, poor, positive, prognosis, quality, rate, reduce, resection, residual, response, second, staging, study, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors Diagnosis
Not obvious early symptoms of ovarian cancer, so early diagnosis depends on the regular census.
1. Past history should be asked whether particular pelvic mass or the recent history of tumor growth. Women over 40 years of age and unexplained gastrointestinal symptoms, and should be gynecological examinations.
2. Body check, can be found abdominal mass, ascites positive sign.
3. Gynecological examinations beside mass, although it is solid or cystic, irregular activities of the poor, and often bilateral. Triple consultation found dome nodule or mass.
4. Auxiliary
| Ovarian cancer | ||
[Summary]
Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus, which ranked third. But ovarian cancer death, accounts of the first gynecologic tumors, right pose a serious threat to women's lives. Because ovarian embryonic development, organization anatomy and endocrine function more complicated, it may be suffering from benign tumors or malignant. Because of early ovarian cancer in asymptomatic, and the identification of its type benign and malignant very difficult, ovarian carcinoma laparotomy in ovarian tumor confined to only 30%, most have spread to the uterus, bilateral annex, the omentum and pelvic organs, both in the diagnosis of ovarian cancer and governance the treatment is a major problem indeed. Over the years experts on the pathological form of ovarian cancer, the development of clinical and treatment programs for many of accumulated a lot of experience, so far, statistics on domestic and foreign clinical data, the five-year survival rate of only 25% to 30%.
Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, care, cases, cause, cell, cells, chemotherapy, clinical, cyst, cystic, days, diagnosis, dose, drug, drugs, early, eat, ert, estrogen, examination, exploration, gene, grams, growth, gynecological, history, incidence, increased, injection, intraperitoneal, intravenous, irradiation, life, lymph, malignant, mass, metastasis, method, node, oppression, ovarian, ovary, pain, patients, pelvic, poor, prognosis, protein, radiation, radiotherapy, rate, reduce, resection, residual, screening, staging, surface, surgery, surgical, survival, symptoms, syndrome, therapy, time, toxicity, treatment, tumor, tumors, uterine, women| Ovarian cancer | ||
Ovarian cancer is a malignancy in ovarian tissue. Clinically, there will be abdominal discomfort, abdominal pain, abdominal mass, menstrual disorders, oppression and other symptoms. Ovarian cancer onset conceal, not found early, easy transfer characteristics of poor prognosis. Of all gynecologic malignancies around 15%. The incidence of ovarian cancer in common malignancy in women as a percentage of 2.4-5.6%. In the female reproductive tract malignancies in the third place, behind cervical and uterine corpus cancer. In women's reproductive tract cancers, ovarian cancer is the highest cause of death of a tumor. Ovarian cancer can occur at any age. Ovarian cancer belong to the medicine "of Zheng Jia", "build up" areas. |
||
The choice of ovarian cancer surgery, chemotherapy and radiotherapy. But because of its pathological type complex, qualitative, without a diagnosis and staging laparoscopy or laparotomy, it is difficult clear. In addition to surgery is not generally the case or have the type of tumor in patients with systemic conditions not competent to surgery, chemotherapy or radiotherapy to trial again after surgery to consider, as appropriate, generally the preferred treatment. Surgical exploration can be further defined tumor types and scope of involvement, clear staging, not only for postoperative chemotherapy and radiotherapy provide basis, and possible removal of the tumor, chemotherapy or postoperative radiotherapy or create conditions to improve efficacy.
Tags: abdominal, age, annex, anti, body, cancer, cases, cause, chemotherapy, clinical, diagnosis, eat, examination, exploration, gene, irradiation, lymph, malignant, node, ovarian, patients, pelvic, poor, positive, radiation, radiotherapy, resection, response, second, staging, surgery, surgical, therapy, time, toxicity, treatment, tumor, tumorsOvarian tumor is not as terrible as people think, the vast majority of ovarian tumors are benign, some of which died of ovarian tumors can be self-healing, such as: ovarian follicle cyst because it is not mature or immature follicles ovulation, the follicle fluid retention and formation. This cyst diameter generally not more than five centimeters, more patients without symptoms, a small number of patients can lower abdomen bulge flu and menstrual disorders, often in a few weeks after their disappearance.
Tags: abdominal, benign, blood, cause, cyst, cysts, diagnosis, early, eat, examination, gene, malignant, ovarian, pain, patients, pelvic, poor, prognosis, surgery, symptoms, tea, time, treatment, tumor, tumors